Top Markets
Coin of the day
Rafael Holdings, Inc. Rafael Holdings, Inc.

Rafael Holdings, Inc.

RFL
Pozycja w akcjach #21321
Rafael Holdings, Inc. holds strategic investments in both early-stage and... Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility. The Pharmaceutical division, conversely, focuses on developing and bringing to market therapies designed to capitalize on the metabolic distinctions between healthy cells and malignant ones. The firm's flagship drug candidate is CPI-613 (devimistat), currently undergoing evaluation in numerous clinical trials, including two pivotal Phase III registrational studies for the treatment of advanced pancreatic cancer and relapsed/refractory acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Cena akcji
$2.15
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$110.06M
Zmiana (1 dzień)
13.46%
Zmiana (1 rok)
37.76%
Kraj
US
Handel Rafael Holdings, Inc. (RFL)

Kategoria

Historia ceny akcji dla Rafael Holdings, Inc. (RFL)
Najwyższa cena zamknięcia: $1.99 dnia 2026-08-01

Najniższa cena zamknięcia: $4.80 dnia 2018-03-01
Historia cen akcji firmy Rafael Holdings, Inc. od 2018 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 18.63%
2025 -30.01%
2024 0.43%
2023 -1.66%
2022 -65.88%
2021 -76.43%
2020 22.88%
2019 122.13%
2018 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$152.07 -7.51%
US
$23.79 -29.07%
DE
$17.70 -4.51%
CN
$38.55 0.00%
DE
$387.58 27.83%
US